Psoriasis News and Research

Latest Psoriasis News and Research

Experts address questions on psoriasis patients’ true needs and wellbeing

Almirall S.A., a global biopharmaceutical company focused on skin health, has hosted a scientific session during the 30th EADV Congress which addressed the need and importance to focus on patient wellbeing in real-life clinical practice.

8 Oct 2021

Glycerin helps calm the red itchy patches in psoriasis model

Patients with psoriasis have reported that glycerin, an inexpensive, harmless, slightly sweet liquid high on the list of ingredients in many skin lotions, is effective at combatting their psoriasis and now scientists have objective evidence to support their reports.

4 Oct 2021

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Real-world data looking at biologic treatment and vaccine hesitancy in psoriasis patients is being presented today at EADV’s 30th Congress.

1 Oct 2021

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

A team of international scientists and clinical experts have unraveled a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO). Their study findings were published in the Journal of Experimental Medicine in September 2021.

17 Sep 2021

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).

14 Sep 2021

Newly developed antibody may be used to treat muscular dystrophy

Northwestern Medicine scientists have developed an antibody that they believe can be used to treat muscular dystrophy, findings that were published in Science Translational Medicine.

13 Sep 2021

How can COVID-19 affect the skin?

A new review published in the journal Canadian Family Physician describes skin diseases caused by the coronavirus disease 2019 (COVID-19).

20 Aug 2021

Hidradenitis suppurativa: Discontinuation of adalimumab prior to surgery is not necessary

Hidradenitis suppurativa (Syn. Acneinversa) is one of the most troublesome and complicated skin diseases. The anti-inflammatory drug adalimumab can improve symptoms; however, patients also often have to undergo surgery.

19 Aug 2021

New evidence-based resources to guide treatment of plaque psoriasis

A range of evidence-based resources are now available from the Targeted Therapies Alliance to assist dermatologists and their patients in shared decision making in the treatment of plaque psoriasis.

17 Aug 2021

Targeting a skin protein may reduce the severity of psoriasis, study reveals

Results from a Michigan Medicine study reveal that targeting a protein found in the skin may reduce the severity of psoriasis.

12 Aug 2021

Investigational treatment improves survival rate of babies lacking thymus

An investigational treatment pioneered by a Duke Health pediatrician resulted in a one-year survival rate of 77% among children born with a rare condition in which they lack an immune system.

4 Aug 2021

Study examines the role of programmed cell death ligands in skin immune responses

T cells are a crucial part of the human adaptive immune system. In response to a foreign invader in the body, various subsets of T cells are responsible for several functions that include killing infected cells and secreting signaling molecules called cytokines that tell other immune cells where to go and what to do.

29 Jul 2021

How a doctor breaks norms to treat refugees and recent immigrants

Fatumo Osman, a 65-year-old Somali refugee who speaks limited English, was in a bind. She made too much money at a meal prep service job so she no longer qualified for Medicaid.

27 Jul 2021

Largest genetic study identifies new drug targets to treat type 1 diabetes

Scientists have completed the largest and most diverse genetic study of type 1 diabetes ever undertaken, identifying new drug targets to treat a condition that affects 1.3 million American adults.

22 Jul 2021

EULAR Patient Research Partners join in new research project to advance treatment of psoriatic arthritis

Eleven Patient Research Partners (PRPs) from three organizations (EULAR, GRAPPA-EU, and EUROPSO) participate in the new research project HIPPOCRATES, ensuring the patients' perspective is preserved and prioritized in all research activities to maximize the project's impact.

2 Jul 2021

NYU Abu Dhabi researchers use NMR spectroscopy to map the structure of specific nanobody

For the first time in the UAE, researchers at NYU Abu Dhabi have used nuclear magnetic resonance techniques to determine the structure of a specific nanobody, Nb23, potentially leading to a better understanding of how this small protein derived from an antibody type, found only in camelids (i.e camels, llamas, and alpacas) and sharks, can fight diseases ranging from rheumatoid arthritis, lupus and psoriasis to lymphoma and breast cancer.

2 Jul 2021

Switching to a balanced diet restores gut health and suppresses skin inflammation

The secret to healthier skin and joints may reside in gut microorganisms. A study led by UC Davis Health researchers has found that a diet rich in sugar and fat leads to an imbalance in the gut's microbial culture and may contribute to inflammatory skin diseases such as psoriasis.

22 Jun 2021

MSU research reveals how the skin's immune cells organize themselves to ward off intruders

It can be easy to forget that the human skin is an organ. It's also the largest one and it's exposed, charged with keeping our inner biology safe from the perils of the outside world.

5 Jun 2021

Methotrexate users fail to achieve adequate immune response to mRNA COVID-19 vaccines

Up to a third of patients taking methotrexate – a common treatment for immune mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis – failed to achieve an adequate immune response to mRNA COVID-19 vaccines in a small study accepted for publication in the journal Annals of the Rheumatic Diseases.

4 Jun 2021

New therapeutic approach developed to treat psoriatic arthritis

An international team of researchers, led by UC Davis Health, has developed a new therapeutic approach to treating psoriatic arthritis, a chronic inflammatory disease affecting the joints.

3 Jun 2021

Psoriasis News and Research

Latest Psoriasis News and Research

Experts address questions on psoriasis patients’ true needs and wellbeing

Glycerin helps calm the red itchy patches in psoriasis model

Real-world data sheds new light on biologic treatment and vaccine hesitancy in psoriasis patients

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Newly developed antibody may be used to treat muscular dystrophy

How can COVID-19 affect the skin?

Hidradenitis suppurativa: Discontinuation of adalimumab prior to surgery is not necessary

New evidence-based resources to guide treatment of plaque psoriasis

Targeting a skin protein may reduce the severity of psoriasis, study reveals

Investigational treatment improves survival rate of babies lacking thymus

Study examines the role of programmed cell death ligands in skin immune responses

How a doctor breaks norms to treat refugees and recent immigrants

Largest genetic study identifies new drug targets to treat type 1 diabetes

EULAR Patient Research Partners join in new research project to advance treatment of psoriatic arthritis

NYU Abu Dhabi researchers use NMR spectroscopy to map the structure of specific nanobody

Switching to a balanced diet restores gut health and suppresses skin inflammation

MSU research reveals how the skin's immune cells organize themselves to ward off intruders

Methotrexate users fail to achieve adequate immune response to mRNA COVID-19 vaccines

New therapeutic approach developed to treat psoriatic arthritis

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Psoriasis News and Research

Latest Psoriasis News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in